By Tom Winnifrith, the Sheriff of AIM | Friday 12 August 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Greg Madison was appointed as CEO of Shield Therapeutics (STX) on June 1 2021. The shares were then 60p. Today they are 8p. In just over a year Greg has presided over a catastrophic 87% destruction of shareholder value. Luckily Greg had no shares himself just a stack of options granted to him two weeks after he joined, to incentivise him.
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Time left: 06:22:43